Search Results - Chad S. Clancy
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
Lack of Lloviu Virus Disease Development in Ferret Model by Paige Fletcher, Kyle L. O’Donnell, Joseph F. Rhoderick, Corey W. Henderson, Atsushi Okumura, Trenton Bushmaker, Ayato Takada, Chad S. Clancy, Gábor Kemenesi, Andrea Marzi
Published in Emerging Infectious Diseases (2024-12-01)Get full text
Article -
5
Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation. by Paige Fletcher, Chad S Clancy, Kyle L O'Donnell, Brianna M Doratt, Delphine C Malherbe, Joseph F Rhoderick, Friederike Feldmann, Patrick W Hanley, Ayato Takada, Ilhem Messaoudi, Andrea Marzi
Published in PLoS Pathogens (2024-06-01)Get full text
Article -
6
Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection by Paige Fletcher, Kyle L. O’Donnell, Brianna M. Doratt, Delphine C. Malherbe, Chad S. Clancy, Joseph F. Rhoderick, Friederike Feldmann, Patrick W. Hanley, Thomas G. Ksiazek, Thomas W. Geisbert, Ilhem Messaoudi, Andrea Marzi
Published in Emerging Microbes and Infections (2023-12-01)Get full text
Article -
7
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease by Thomas P. Monath, Thomas P. Monath, Richard Nichols, Friederike Feldmann, Amanda Griffin, Elaine Haddock, Julie Callison, Kimberly Meade-White, Atsushi Okumura, Jamie Lovaglio, Patrick W. Hanley, Chad S. Clancy, Carl Shaia, Wasima Rida, Joan Fusco
Published in Frontiers in Immunology (2023-09-01)Get full text
Article -
8
Highly pathogenic avian influenza H5N1 clade 2.3.4.4b genotype B3.13 is highly virulent for mice, rapidly causing acute pulmonary and neurologic disease by Thomas Tipih, Vignesh Mariappan, Kwe C. Yinda, Kimberly Meade-White, Matthew Lewis, Atsushi Okumura, Natalie McCarthy, Ekaterina Altynova, Shanna S. Leventhal, Trenton Bushmaker, Chad S. Clancy, Emmie de Wit, Vincent J. Munster, Heinz Feldmann, Kyle Rosenke
Published in Nature Communications (2025-07-01)Get full text
Article -
9
Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2 by Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, Paul J. Baker, Samuel I. Old, Victoria Peluf, Eduardo P. Amaral, Sandra D. Oland, Danielle O’Mard, Julie Laux, Melanie Cohen, Nicole L. Garza, Bernard A. P. Lafont, Reed F. Johnson, Carl G. Feng, Dragana Jankovic, Olivier Lamiable, Katrin D. Mayer-Barber, Alan Sher
Published in Nature Communications (2023-12-01)Get full text
Article -
10
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19 by Shelly J. Robertson, Olivia Bedard, Kristin L. McNally, Carl Shaia, Chad S. Clancy, Matthew Lewis, Rebecca M. Broeckel, Abhilash I. Chiramel, Jeffrey G. Shannon, Gail L. Sturdevant, Rebecca Rosenke, Sarah L. Anzick, Elvira Forte, Christoph Preuss, Candice N. Baker, Jeffrey M. Harder, Catherine Brunton, Steven Munger, Daniel P. Bruno, Justin B. Lack, Jacqueline M. Leung, Amirhossein Shamsaddini, Paul Gardina, Daniel E. Sturdevant, Jian Sun, Craig Martens, Steven M. Holland, Nadia A. Rosenthal, Sonja M. Best
Published in Nature Communications (2023-07-01)Get full text
Article
